Literature DB >> 8099367

Ipecac myopathy and cardiomyopathy.

L P Dresser1, E W Massey, E E Johnson, E Bossen.   

Abstract

Two cases of ipecac myopathy, one with associated cardiomyopathy are reported. Both patients were young women with eating disorders who came to medical attention because of diffuse muscle weakness. Clinical and electromyographic data suggested ipecac myopathy and muscle biopsies confirmed this diagnosis. One patient had associated clinical and echocardiographic evidence of significant cardiomyopathy. The myopathy resolved and the echocardiogram returned to normal after discontinuing the use of ipecac.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099367      PMCID: PMC1015020          DOI: 10.1136/jnnp.56.5.560

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  Death resulting from ipecac syrup poisoning.

Authors:  A G Adler; P Walinsky; R A Krall; S Y Cho
Journal:  JAMA       Date:  1980-05-16       Impact factor: 56.272

2.  A case of abuse of syrup of ipecac resulting in death.

Authors:  J A Dawson; J Yager
Journal:  J Am Coll Health       Date:  1986-06

3.  The epidemiology of ipecac abuse.

Authors:  H G Pope; J I Hudson; R A Nixon; P L Herridge
Journal:  N Engl J Med       Date:  1986-01-23       Impact factor: 91.245

4.  Fibre type changes in striated muscle of alcoholics.

Authors:  A Hanid; G Slavin; W Mair; C Sowter; P Ward; J Webb; J Levi
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

5.  Toxicology of ipecac: a review.

Authors:  B R Manno; J E Manno
Journal:  Clin Toxicol       Date:  1977       Impact factor: 4.467

6.  Ipecac-induced myopathy simulating dermatomyositis.

Authors:  H S Bennett; A J Spiro; M A Pollack; P Zucker
Journal:  Neurology       Date:  1982-01       Impact factor: 9.910

7.  Emetine myopathy: two case reports with pathobiochemical analysis.

Authors:  H Sugie; R Russin; M A Verity
Journal:  Muscle Nerve       Date:  1984-01       Impact factor: 3.217

8.  Ultrastructural pathology in emetine-induced myopathy.

Authors:  L Halbig; L Gutmann; H H Goebel; J F Brick; S Schochet
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  Experimental (-) emetine myopathy. Ultrastructural and morphometric observations.

Authors:  L Bindoff; M J Cullen
Journal:  J Neurol Sci       Date:  1978-11       Impact factor: 3.181

10.  Reversible ipecac myopathy.

Authors:  J E Mateer; B J Farrell; S S Chou; L Gutmann
Journal:  Arch Neurol       Date:  1985-02
  10 in total
  6 in total

Review 1.  The medical complications associated with purging.

Authors:  K Jean Forney; Jennifer M Buchman-Schmitt; Pamela K Keel; Guido K W Frank
Journal:  Int J Eat Disord       Date:  2016-02-15       Impact factor: 4.861

2.  Cardiotoxicity of emetine dihydrochloride by calcium channel blockade in isolated preparations and ventricular myocytes of guinea-pig hearts.

Authors:  R Lemmens-Gruber; A Karkhaneh; C Studenik; P Heistracher
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

3.  Absorption, distribution and excretion of 3H-labeled cephaeline- and emetine-spiked ipecac syrup in rats.

Authors:  Takayuki Asano; Kazuhisa Ishihara; Yoko Wakui; Toshihiko Yanagisawa; Masayuki Kimura; Hideo Kamei; Takemi Yoshida; Yukio Kuroiwa; Yuichi Fujii; Mamoru Yamashita; Takanori Kuramochi; Hiroki Tomisawa; Mitsuru Tateishi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.441

Review 4.  [Anesthesia in patients with anorexia nervosa and bulimia nervosa].

Authors:  J Zenker; U Hagenah; R Rossaint
Journal:  Anaesthesist       Date:  2010-03       Impact factor: 1.041

Review 5.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

6.  Biotransformation of the ipecac alkaloids cephaeline and emetine from ipecac syrup in rats.

Authors:  Takayuki Asano; Junko Watanabe; Chiharu Sadakane; Kazuhisa Ishihara; Kazuhiro Hirakura; Yoko Wakui; Toshihiko Yanagisawa; Masayuki Kimura; Hideo Kamei; Takemi Yoshida; Yuichi Fujii; Mamoru Yamashita
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.